Civeo Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Civeo Corporation on July 25, 2014. The filing reports corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new director, along with modifications to director indemnification agreements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed relates to director compensation: C. Ronald Blankenship was granted restricted stock awards valued at $125,000 (4,926 shares).
Material Changes
- Board Expansion: The Board of Directors expanded from eight to nine members.
- New Appointment: C. Ronald Blankenship was appointed as a Class I director to fill the newly created seat.
- Compensation: Mr. Blankenship received restricted stock awards valued at $125,000 and will be compensated under the company's standard arrangement for non-employee directors.
- Indemnification Update: The Board approved a modification to the form of indemnification agreement, requiring the company to maintain directors and officers liability insurance on terms no less favorable than those in effect on the date of the amendment.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies were disclosed in this report, other than the standard disclosure that the company is not aware of any arrangements influencing the director's selection or transactions requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the total number of board seats and the composition of standing committees following Mr. Blankenship's appointment.
- Confirm the specific terms of the "standard arrangement" for director compensation referenced in the Form 10 registration statement.
- Review the full text of the modified indemnification agreement to understand the specific insurance coverage requirements.
- Check for subsequent filings regarding Mr. Blankenship's assignment to any standing committees.